{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:52:30Z","timestamp":1774263150518,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Plastic, Reconstructive & Aesthetic Surgery"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.bjps.2006.06.016","type":"journal-article","created":{"date-parts":[[2006,9,13]],"date-time":"2006-09-13T11:16:41Z","timestamp":1158146201000},"page":"99-106","source":"Crossref","is-referenced-by-count":13,"title":["Jaw avascular osteonecrosis after treatment of multiple myeloma with zoledronate"],"prefix":"10.1016","volume":"61","author":[{"given":"J.V.","family":"Lobato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Maur\u00edcio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.V.","family":"Cavaleiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.P.","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Botelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Sooraj","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bjps.2006.06.016_bib1","first-page":"291","article-title":"Bone destruction and hypercalcemia in plasma cell myeloma","volume":"13","author":"Mundy","year":"1986","journal-title":"Semin Oncol"},{"issue":"8","key":"10.1016\/j.bjps.2006.06.016_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1200\/JCO.1991.9.8.1397","article-title":"Effect of daily etidronate on the osteolysis of multiple myeloma","volume":"9","author":"Belch","year":"1991","journal-title":"J Clin Oncol"},{"issue":"26","key":"10.1016\/j.bjps.2006.06.016_bib3","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM197512252932602","article-title":"Multiple myeloma bone disease. The comparative effect of sodium fluoride and calcium carbonate or placebo","volume":"293","author":"Kyle","year":"1975","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bjps.2006.06.016_bib4","first-page":"29","article-title":"Multiple myeloma: review of 869 cases","volume":"50","author":"Kyle","year":"1975","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.bjps.2006.06.016_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bcmd.2004.01.001","article-title":"Pathogenesis of myeloma bone disease","volume":"32","author":"Roodman","year":"2004","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"10.1016\/j.bjps.2006.06.016_bib6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.beha.2005.03.001","article-title":"Myeloma bone disease","volume":"18","author":"Berenson","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bjps.2006.06.016_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggerio","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"issue":"12","key":"10.1016\/j.bjps.2006.06.016_bib8","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI118722","article-title":"Bisphosphonates: mechanism of action","volume":"97","author":"Rodan","year":"1996","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.bjps.2006.06.016_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"10.1016\/j.bjps.2006.06.016_bib10","first-page":"389","article-title":"Antiresorptive dose\u2013response relationship across three generations of bisphosphonates","volume":"15","author":"Sietsema","year":"1989","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.bjps.2006.06.016_bib11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF02555748","article-title":"Quantitative morphometric evaluation of the inhibitory activity of new amino-bisphosphonates on bone resorption in the rat","volume":"38","author":"Schenk","year":"1986","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"10.1016\/j.bjps.2006.06.016_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02547227","article-title":"The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals","volume":"11","author":"Jung","year":"1973","journal-title":"Calcif Tissue Res"},{"issue":"2","key":"10.1016\/j.bjps.2006.06.016_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00002512-199812020-00007","article-title":"Pamidronate. A review of its use in the management of osteolytic bone metastases, tumor-induced\u00a0hypercalcaemia and Paget's disease of bone","volume":"12","author":"Coukell","year":"1998","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.bjps.2006.06.016_bib14","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1172\/JCI114100","article-title":"Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow","volume":"83","author":"Hughes","year":"1989","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.bjps.2006.06.016_bib15","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo","volume":"10","author":"Hughes","year":"1995","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.bjps.2006.06.016_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S8756-3282(95)00150-6","article-title":"A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders","volume":"17","author":"Murakami","year":"1995","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bjps.2006.06.016_bib17","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1172\/JCI116422","article-title":"Bisphosphonates act on rat bone resorption through the mediation of osteoblasts","volume":"91","author":"Sahni","year":"1993","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.bjps.2006.06.016_bib18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/er.19.1.80","article-title":"Bisphosphonates: mechanisms of action","volume":"19","author":"Fleisch","year":"1998","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.bjps.2006.06.016_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02405012","article-title":"Structure\u2013activity relationships of various bisphosphonates","volume":"35","author":"Shinoda","year":"1983","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.bjps.2006.06.016_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/082585979801400205","article-title":"The role of bisphosphonates in malignant bone pain: a review","volume":"14","author":"Pereira","year":"1998","journal-title":"J Palliat Care"},{"issue":"5","key":"10.1016\/j.bjps.2006.06.016_bib21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/bjc.1995.502","article-title":"A randomized double-blind comparison of intravenous pamidronate and clodronate in the hypercalcemia of malignancy","volume":"72","author":"Purohit","year":"1995","journal-title":"Br J Cancer"},{"issue":"21","key":"10.1016\/j.bjps.2006.06.016_bib22","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer","volume":"21","author":"Hillner","year":"2003","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.bjps.2006.06.016_bib23","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1200\/JCO.2000.18.6.1378","article-title":"American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel","volume":"18","author":"Hillner","year":"2000","journal-title":"J Clin Oncol"},{"issue":"5 Suppl. 16","key":"10.1016\/j.bjps.2006.06.016_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.seminoncol.2003.08.017","article-title":"Zoledronic acid for the treatment of bone metastases in patients with breast cancer and other solid tumours","volume":"30","author":"Lacerna","year":"2003","journal-title":"Semin Oncol"},{"issue":"4 Suppl. 11","key":"10.1016\/j.bjps.2006.06.016_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0093-7754(01)90233-7","article-title":"Use of markers of bone turnover for monitoring bone metastases and the response to therapy","volume":"28","author":"Lipton","year":"2001","journal-title":"Semin Oncol"},{"issue":"2","key":"10.1016\/j.bjps.2006.06.016_bib26","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1046\/j.1365-2141.1998.00695.x","article-title":"Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish\u2013Swedish Co-operative Study Group","volume":"101","author":"Brincker","year":"1998","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.bjps.2006.06.016_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.1998.16.2.593","article-title":"Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group","volume":"16","author":"Berenson","year":"1998","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.bjps.2006.06.016_bib28","first-page":"478","article-title":"Phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases","volume":"7","author":"Berenson","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.bjps.2006.06.016_bib29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/107327480200900605","article-title":"The use of bisphosphonates in patients with breast cancer","volume":"9","author":"Van Poznak","year":"2002","journal-title":"Cancer Control"},{"issue":"9","key":"10.1016\/j.bjps.2006.06.016_bib30","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"10.1016\/j.bjps.2006.06.016_bib31","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2141.2005.05382.x","article-title":"Osteonecrosis of the jaw associated with zoledronate therapy in patient with multiple myeloma","volume":"128","author":"Vannucchi","year":"2005","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.bjps.2006.06.016_bib32","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","article-title":"Osteonecrosis of the jaws associated with cancer chemotherapy","volume":"61","author":"Wang","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"8","key":"10.1016\/j.bjps.2006.06.016_bib33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5694\/j.1326-5377.2005.tb06762.x","article-title":"Bisphosphonates and osteonecrosis of the jaw","volume":"182","author":"Purcell","year":"2005","journal-title":"Med J Aust"},{"issue":"8","key":"10.1016\/j.bjps.2006.06.016_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5694\/j.1326-5377.2005.tb06761.x","article-title":"Bisphosphonates and avascular necrosis of the jaw: a possible association","volume":"182","author":"Carter","year":"2005","journal-title":"Med J Aust"},{"key":"10.1016\/j.bjps.2006.06.016_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.bjps.2006.06.016_bib36","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphonates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bjps.2006.06.016_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.47102\/annals-acadmedsg.V33N4p48S","article-title":"Bisphosphonates \u2013 a word of caution","volume":"33","author":"Robinson","year":"2004","journal-title":"Ann Acad Med Singapore"},{"issue":"1","key":"10.1016\/j.bjps.2006.06.016_bib38","first-page":"74","article-title":"Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: a case report","volume":"10","author":"Starck","year":"1995","journal-title":"Int J Oral Maxillofac Implants"},{"issue":"2","key":"10.1016\/j.bjps.2006.06.016_bib39","first-page":"111","article-title":"Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy","volume":"71","author":"Melo","year":"2005","journal-title":"J Can Dent Assoc"}],"container-title":["Journal of Plastic, Reconstructive & Aesthetic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1748681506004827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1748681506004827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T12:08:56Z","timestamp":1707221336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1748681506004827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1748681506004827"],"URL":"https:\/\/doi.org\/10.1016\/j.bjps.2006.06.016","relation":{},"ISSN":["1748-6815"],"issn-type":[{"value":"1748-6815","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}